153 related articles for article (PubMed ID: 28346002)
1. Quality assessment of fluconazole capsules and oral suspensions compounded by pharmacies located in the United States.
Laporte CM; Cruz-Espindola C; Thungrat K; Schick AE; Lewis TP; Boothe DM
Am J Vet Res; 2017 Apr; 78(4):421-432. PubMed ID: 28346002
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and precision of compounded ciclosporin capsules and solution.
Umstead ME; Boothe DM; Cruz-Espindola C; Macdonald JM; Kennis R; Angarano D
Vet Dermatol; 2012 Oct; 23(5):431-e82. PubMed ID: 22970897
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of drug content (potency) for compounded and FDA-approved formulations of doxycycline on receipt and after 21 days of storage.
KuKanich K; KuKanich B; Slead T; Warner M
J Am Vet Med Assoc; 2017 Oct; 251(7):835-842. PubMed ID: 28967825
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the quality of simvastatin capsules from compounding pharmacies.
Markman BE; Rosa PC; Koschtschak MR
Rev Saude Publica; 2010 Dec; 44(6):1055-62. PubMed ID: 21107503
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of commercially manufactured and compounded protamine zinc insulin.
Scott-Moncrieff JC; Moore GE; Coe J; Lynn RC; Gwin W; Petzold R
J Am Vet Med Assoc; 2012 Mar; 240(5):600-5. PubMed ID: 22332631
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical evaluation of compounded trilostane products.
Cook AK; Nieuwoudt CD; Longhofer SL
J Am Anim Hosp Assoc; 2012; 48(4):228-33. PubMed ID: 22611212
[TBL] [Abstract][Full Text] [Related]
7. Variable accuracy, precision, and consistency of compounded famciclovir formulated for management of feline herpesvirus-1 in cats.
O'Leary LM; Allbaugh RA; Schrunk DE; Olsen TE; Sebbag L
Vet Ophthalmol; 2021 Nov; 24(6):627-638. PubMed ID: 34117694
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of testosterone concentrations in compounded testosterone products.
Grober ED; Garbens A; Božović A; Kulasingam V; Fanipour M; Diamandis EP
J Sex Med; 2015 Jun; 12(6):1381-8. PubMed ID: 25963000
[TBL] [Abstract][Full Text] [Related]
9. Analysis of lomustine drug content in FDA-approved and compounded lomustine capsules.
KuKanich B; Warner M; Hahn K
J Am Vet Med Assoc; 2017 Feb; 250(3):322-326. PubMed ID: 28117638
[TBL] [Abstract][Full Text] [Related]
10. Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules.
Dijkers E; Nanhekhan V; Thorissen A; Polonini H
Int J Pharm Compd; 2017; 21(2):171-175. PubMed ID: 28346214
[TBL] [Abstract][Full Text] [Related]
11. Stability and consistency of compounded oral liquid levothyroxine formulations.
Meyer LM; Stephens K; Carter CA; Pickard W; Johnson PR; Eagerton DH
J Am Pharm Assoc (2003); 2020; 60(6):e168-e172. PubMed ID: 32591200
[TBL] [Abstract][Full Text] [Related]
12. Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
Friciu M; Zaraa S; Roullin VG; Leclair G
PLoS One; 2016; 11(10):e0164577. PubMed ID: 27727306
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Peacock GF; Sauvageot J; Hill A; Killian A
Int J Pharm Compd; 2016; 20(1):81-5. PubMed ID: 27125058
[TBL] [Abstract][Full Text] [Related]
15. Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies.
Stanczyk FZ; Niu C; Azen C; Mirkin S; Amadio JM
Menopause; 2019 Sep; 26(9):966-971. PubMed ID: 31453957
[TBL] [Abstract][Full Text] [Related]
16. Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals.
Petritz OA; Guzman DS; Wiebe VJ; Papich MG
J Am Vet Med Assoc; 2013 Jul; 243(1):85-90. PubMed ID: 23786194
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
[TBL] [Abstract][Full Text] [Related]
18. Challenge of paediatric compounding to solid dosage forms sachets and hard capsules - Finnish perspective.
Sivén M; Kovanen S; Siirola O; Hepojoki T; Isokirmo S; Laihanen N; Eränen T; Pellinen J; Juppo AM
J Pharm Pharmacol; 2017 May; 69(5):593-602. PubMed ID: 27704551
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three pharmaceutical products obtained from Mexico and the United States: a case study.
Karlage KL; Myrdal PB
Drug Dev Ind Pharm; 2005 Dec; 31(10):993-1000. PubMed ID: 16316855
[TBL] [Abstract][Full Text] [Related]
20. Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.
Adin D; Johnson PR; Kim CH; Nguyenba T; Rosen S
J Vet Intern Med; 2017 Nov; 31(6):1822-1826. PubMed ID: 28913839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
